Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BGQOD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
ADCT-901
|
|||||
| Synonyms |
3A4-PL1601; ADCT 901; ADCT-901; ADCT901
Click to Show/Hide
|
|||||
| Organization |
ADC Therapeutics SA; Overland Pharmaceuticals
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Structure |
|
|||||
| Antibody Name |
Olintatug
|
Antibody Info | ||||
| Antigen Name |
Kidney-associated antigen 1 (KAAG1)
|
Antigen Info | ||||
| Payload Name |
SG3199
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Mal-PEG8-Val-Ala-PABC
|
Linker Info | ||||
| Conjugate Type |
Random Lysines
|
|||||
| Combination Type |
tesirine
|
|||||
